Home » Stocks » TransEnterix

TransEnterix, Inc. (TRXC)

Stock Price: $0.440 USD -0.018 (-3.85%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed
After-hours: $0.440 +0.000 (0.02%) Aug 7, 8:00 PM

Stock Price Chart

Key Info

Market Cap 43.95M
Revenue (ttm) 3.97M
Net Income (ttm) -141.94M
Shares Out 99.88M
EPS (ttm) -4.80
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $0.440
Previous Close $0.458
Change ($) -0.018
Change (%) -3.85%
Day's Open 0.450
Day's Range 0.420 - 0.450
Day's Volume 2,180,993
52-Week Range 0.280 - 15.470

More Stats

Market Cap 43.95M
Enterprise Value 30.53M
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 99.88M
Float 41.61M
EPS (basic) -6.82
EPS (diluted) -4.80
FCF / Share -0.83
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.51M
Short Ratio 0.35
Short % of Float 2.54%
Beta 2.70
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 11.08
PB Ratio 0.73
Revenue 3.97M
Operating Income -151.91M
Net Income -141.94M
Free Cash Flow -43.37M
Net Cash 13.42M
Net Cash / Share 0.13
Gross Margin -120.83%
Operating Margin -3,830.41%
Profit Margin -3,596.90%
FCF Margin -1,093.49%
ROA -31.95%
ROE -148.60%
ROIC -486.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 1
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

$1.75*
Low
1.75
Current: $0.440
High
1.75
Target: 1.75
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue8.5324.107.111.52-0.401.432.12--
Revenue Growth-64.6%238.94%368.14%---71.98%-32.34%---
Gross Profit-12.207.930.380.45--0.69-3.38-2.31--
Operating Income-164-50.16-59.27-123-46.77-36.61-25.60-15.07-5.67-5.35
Net Income-154-61.78-145-120-46.95-37.65-28.36-15.43-5.76-5.30
Shares Outstanding17.7415.9411.448.636.124.520.980.080.430.34
Earnings Per Share-8.69-3.88-12.61-13.91-7.67-8.32-28.99-185.91-13.65-30.55
Operating Cash Flow-73.48-48.49-47.30-52.39-38.76-33.35-21.24-14.15-4.87-4.53
Capital Expenditures15.53-0.74-1.99-1.36-1.23-2.15-1.38-0.14-0.29-0.28
Free Cash Flow-57.96-49.23-49.29-53.75-39.99-35.50-22.61-14.28-5.16-4.81
Cash & Equivalents10.5773.4497.6134.5938.4535.0216.5810.180.303.03
Total Debt-28.9413.1712.9919.729.798.4810.002.520.05
Net Cash / Debt10.5744.5084.4321.6018.7325.238.100.18-2.232.98
Assets74.7823925017624913511717.560.993.69
Liabilities19.2470.7971.4058.3871.3313.3211.6911.172.990.27
Book Value55.54169179118177122105-68.61-2.003.42
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name TransEnterix, Inc.
Country United States
Employees 160
CEO Anthony Fernando

Stock Information

Ticker Symbol TRXC
Stock Exchange NYSE American
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSEAMERICAN: TRXC

Description

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company's products include Senhance System, a multi-port robotic surgery system that allows multiple robotic arms to control instruments and a camera; and SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform. It offers its products directly and through distributors in Europe, the United States, Japan, Taiwan, and other select countries. The company was founded in 2006 and is based in Morrisville, North Carolina.